Caricamento...
Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report
INTRODUCTION: Patients who receive or have received anti-programmed cell-death-1 (PD-1) monoclonal antibodies can develop immune-related adverse events due to activation of the immune system. CASE PRESENTATION: We report a case of a patient who received pembrolizumab and presented with cardiac tampo...
Salvato in:
| Pubblicato in: | Eur Heart J Case Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177032/ https://ncbi.nlm.nih.gov/pubmed/31020118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcr/yty038 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|